+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Mantle Cell Lymphoma Therapeutics Global Market Report 2024 - Product Thumbnail Image

Mantle Cell Lymphoma Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Gene Therapy Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Gene Therapy Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
Myelodysplastic Syndrome Global Market Report 2024 - Product Thumbnail Image

Myelodysplastic Syndrome Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Leukemia Therapeutics Global Market Report 2024 - Product Thumbnail Image

Leukemia Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Gastroenterology Market - Global Forecast Report 2024-2032 - Product Thumbnail Image

Gastroenterology Market - Global Forecast Report 2024-2032

  • Report
  • September 2023
  • 160 Pages
  • Global
From
From
From
Protein Kinase C Theta Type - Pipeline Review, H2 2020 - Product Thumbnail Image

Protein Kinase C Theta Type - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 33 Pages
  • Global
From
From
From
Acute Myeloid Leukemia (AML) Treatment Market in APAC 2024-2028 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Treatment Market in APAC 2024-2028

  • Report
  • October 2024
  • 126 Pages
  • Asia Pacific
From
From
From
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2024 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Loading Indicator